Navigation Links
Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity
Date:9/10/2013

ferent asthma severities who remain symptomatic on current treatment with ICS. The program includes over 4,000 patients in more than 150 sites globally. Results from the PrimoTinA-asthma® studies in severe asthma patients, part of the UniTinA-asthma® program, were presented at the 2012 ERS Congress in Vienna, Austria, with additional sub-analyses presented at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting and the American Thoracic Society (ATS) International Conference.

About Asthma
Asthma is a chronic disease characterized by airway inflammation and bronchoconstriction. When a person with asthma comes into contact with an asthma trigger (e.g. infections, pollen, smoke), their airways can become inflamed, swollen and constricted and excess mucus is produced. These reactions can cause the airways to become narrower and irritated, making it difficult to breathe. People suffering from asthma experience recurrent episodes of wheezing, breathlessness, chest tightness and coughing. Asthma attacks occur when symptoms become more intense or frequent.

As of December 2012, an estimated 300 million people worldwide suffer from asthma. Estimates have shown that the number of people with asthma could grow by an additional 100 million people worldwide by 2025.

By avoiding asthma triggers, one can help to reduce the severity of asthma. Although asthma cannot be cured, appropriate management can control the disease in many patients. However, at least 40 percent of patients still suffer from uncontrolled asthma and may experience life-threatening asthma exacerbations despite the available treatment options. They can continue to have symptoms and lifestyle restrictions and might even require emergency care.

Leading Respiratory Forward
Through research, treatments and patient-centric support services, the Boehringer Ingelheim lung health portfolio is de
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takedas New Investigational Drug Vedolizumab is Granted Priority Review Status by U.S. Food and Drug Administration for Ulcerative Colitis
2. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
3. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
4. New Data for Abbotts Investigational High Sensitive Troponin Test Shows It May Help Doctors Predict Heart Attack Risk
5. Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
6. Signum Dermalogix Investigational New Drug (IND) Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea
7. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
8. Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
9. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
10. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
11. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 A study led by St. ... chemotherapy dose threshold below which male childhood cancer survivors ... appears in September 17 edition of the journal ... are at highest risk for reduced sperm production as ... of pre-treatment fertility preservation methods such as sperm banking. ...
(Date:9/16/2014)... CHICAGO , Sept. 16, 2014 The ... submitted survey data from more than 1,100 patients and ... Food and Drug Administration (FDA) for the Patient-Focused Drug ... This is a new FDA initiative to seek patient ... expectations for therapeutic treatments. "We applaud the ...
(Date:9/16/2014)... 2014 Astellas announced today it has ... & Advocacy, Urology in the Americas. Noland will report ... Margaret Long. In this role, Noland will be responsible ... and advocacy organizations, as well as collaborating with ... Noland,s appointment is the latest phase in the ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 3PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 4Christy Noland to Lead Urology Advocacy and Communications for Astellas 2
(Date:9/17/2014)... 17, 2014 U.S. News and ... the country, and three mesothelioma treatment centers made ... the mesothelioma law firm Baron and Budd ... University of Texas MD Anderson Cancer Center and ... publication. ( http://health.usnews.com/best-hospitals/rankings/cancer ) , U.S. News and ...
(Date:9/17/2014)... DMG Productions announces the upcoming ... to broadcast on Wednesday, September 24, 2014 at ... this episode, Innovations will go behind the scenes ... provide each client the opportunity to achieve the ... the principles of Care, Compassion, and Commitment. , ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Experienced dress ... making a new selection of trendy black bridesmaid dresses. ... for all its beautiful bridesmaid outfits. Readers can ... , Discount-Dress.com is a famous brand ... of new additions as well as revamped old editions, ...
(Date:9/17/2014)... Headquartered in Baltimore, Maryland, Therapy ... the country. , “The past two weeks have ... grown to over 400 evaluators in 46 states, and ... the Midwest and South Dakota and Vermont. And from ... our volunteers can visit.” , TPU provides one-of-a-kind treatment ...
(Date:9/17/2014)... Request A Test , a leading national provider of ... drug testing through the end of September 2014. ... by employers for workplace or new hire screenings. Employers ... promo code DRUG10 when placing an order. Statistics have ... especially for marijuana or THC. Request A Test offers ...
Breaking Medicine News(10 mins):Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:Therapy Pets Unlimited is Expanding 2Health News:Therapy Pets Unlimited is Expanding 3Health News:Request A Test Can Save You 10% on Drug Testing 2Health News:Request A Test Can Save You 10% on Drug Testing 3
... Heart patients and cardiologists across the country are ... access be preserved as discussions about healthcare ... for Medicare and Medicaid Services (CMS) - scheduled to ... the accessibility of life-saving cardiology testing and services currently ...
... Health System study has found that high-risk surgery ... were seen by general internists trained in managing ... underwent high-risk orthopaedic surgeries experienced shorter stays when ... surgeons. And, the study found, patients reported they ...
... true for current H1N1 strain remains a mystery, , THURSDAY, ... 1918 Spanish flu pandemic while still in their mother,s womb ... 60 years later, a new study has found. , The ... people worldwide, including 500,000 in the United States. That flu, ...
... Effort Illustrates Broad Public Support for Addressing Crisis ... Oct. 1 Citizens of Delaware ... and wellness with the launch today of "Say ,Yes, to ... video campaign of the Partnership to Fight Chronic Disease (PFCD) ...
... Pink Sheets Filings Reply To Shareholders ... General Corporate Update, , SHENZHEN, China, Oct. 1 /PRNewswire-FirstCall/ ... based operating subsidiary Mellow Hope and Serbia operating Subsidiary ... attention to today,s Pink Sheets filing. The filing found ...
... Whether they can have children is one of the ... cancer because fertility can be compromised by cancer treatment. ... studies led by researchers at Fred Hutchinson Cancer Research ... will adversely impact their newborns. The studies, presented as ...
Cached Medicine News:Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 2Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 3Health News:How to reduce hospital stays and increase patient satisfaction 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 3Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 2Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 3Health News:Hard to Treat Diseases (HTDS) Management Discussion 2Health News:Hard to Treat Diseases (HTDS) Management Discussion 3Health News:Studies find few risks to newborn offspring of parents who are childhood cancer survivors 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: